Rare diseases
Investigational molecules
Locations
Back to Bulgaria168 clinical trials in Stara Zagora, Bulgaria across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
BulgariaStudy on Long-Term Safety of Itepekimab for Patients with Chronic Obstructive Pulmonary Disease (COPD)
BulgariaStudy on the Safety and Effectiveness of Ritlecitinib in Adults and Adolescents with Nonsegmental Vitiligo
BulgariaStudy on the Effects of Verekitug (UPB-101) for Adults with Severe Asthma
BulgariaStudy Comparing RBS-001 and Aflibercept for Patients with Neovascular Age-Related Macular Degeneration
BulgariaStudy on the Long-Term Safety of Povorcitinib for Patients with Moderate to Severe Hidradenitis Suppurativa
BulgariaStudy on the Safety and Effectiveness of Tovinontrine for Adults with Chronic Heart Failure with Reduced Ejection Fraction
BulgariaStudy on the Effectiveness and Safety of OCS-01 Eye Drops with Dexamethasone for Patients with Diabetic Macular Edema
BulgariaStudy on the Safety and Effectiveness of Tovinontrine for Adults with Chronic Heart Failure with Preserved Ejection Fraction
BulgariaStudy on Long-Term Use of Spesolimab for Patients with Hidradenitis Suppurativa Who Completed a Previous Spesolimab Study
BulgariaStudy Comparing Ibrexafungerp and Fluconazole for Treating Candidemia or Invasive Candidiasis in Patients
BulgariaStudy on Inclisiran and Rosuvastatin for Lowering Cholesterol in Patients with High Cholesterol Levels
BulgariaThe busiest research cities in the country
What the registry says about research in the country
Clinical trials focusing on inflammatory disorders are evaluating novel treatments for conditions including psoriatic arthritis and hidradenitis suppurativa. Researchers are testing innovative therapies targeting specific inflammatory pathways.
These studies aim to improve quality of life for patients with chronic inflammatory conditions.
Research in respiratory diseases includes multiple trials investigating new treatments for asthma. Studies are examining both established and experimental medications to enhance breathing function and disease control.
Emphasis is placed on developing treatments for moderate to severe cases.
Groundbreaking research in blood cancers and solid tumors includes studies on acute myeloid leukemia, chronic lymphocytic leukemia, and prostate cancer. Novel therapeutic approaches are being evaluated.
These trials aim to improve survival rates and treatment outcomes.
Studies in neurological disorders are investigating treatments for epilepsy and examining extended-release formulations of existing medications to improve seizure control.
Focus is on developing more effective treatment options for patients with refractory conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
